Latest filing published 06 Dec 2019 for Adicet Bio, Inc..
Insider track record
No signal scores available.
Joan Mannick: trading record in brief
Joan Mannick discloses dealings in Adicet Bio, Inc. to SEC (Form 4). We count 3 filings; the first trade dates from 26 October 2018 and the latest from 6 December 2019.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 6 December 2019 came the latest disclosure, a share grant in Adicet Bio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 52 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Joan Mannick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 118,222 shares0Common StockSEC:0000899243-19-028707:0
- 600,000 shares0Common StockSEC:0000899243-18-031271:0
- 600,000 shares0Common StockSEC:0000899243-18-031271:1
3 of 3 declarations
